Neurotoxicity associated with acyclovir in end stage renal failure

New Zealand Medical Journal

Volumn 110, Issue 1043, 1997, Pages 167-169

  Kitching, A Richard ^a   Fagg, Dianne ^c   Hay, Nicola M ^c   Hatfield, Peter J ^c   Macdonald, Alastair ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b WELLINGTON HOSPITAL   (New Zealand)

^c Wellington Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ADULT; AGED; ARTICLE; CASE REPORT; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; HERPES ZOSTER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; NEUROTOXICITY;

ACYCLOVIR; AGED; ANTIVIRAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HERPES ZOSTER; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; NERVOUS SYSTEM; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY;

EID: 0030922313     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Wagstaff AJ, Faulds D, Goa KL. Acyclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1994; 47: 153-205.
2. Adis Press International. New Ethicals Compendium. Auckland: Adis Press Ltd, 1994.
3. Haefeli WE, Schoenenberger RAZ, Weiss P, Ritz RF. Acyclovir-induced neurotoxicity: concentration side effect relationship in acyelovir overdose. Am J Med 1993; 94: 212-5.
4. Rashiq S, Briewa L, Mooney M, et al. Distinguishing acyclovir neurotoxicity from encephalomyelitis. Intern Med 1993; 234: 507-11.
5. Johnson R, Douglas J, Corey L, Krasney H. Adverse effects with acyclovir and meperidine (letter). Ann Intern Med 1985; 103: 962-3.
6. Jones PG, Beier-Hanratty SA. Acyclovir: Neurologic and renal toxicity (letter). Ann Intern Med 1986; 104: 892.
7. Spiegal DM, Lau K. Acute renal failure and coma secondary to acyclovir therapy (letter). JAMA 1986; 255: 1882-3.
8. Tomson CR, Goodship THJ, Rodger RSC. Psychiatric side effects of acyclovir in patients with chronic renal failure (letter). Lancet 1985; 2; 385-6.
9. Bataille P, Devos P, Noel JL. Psychiatric side-effects with acyclovir (letter). Lancet 1985; 2: 724.
10. Vartian CV, Shlaes DM. Intravenous acyclovir and neurologic effects (letter). Ann Intern Med 1983; 99: 568.
11. Cohen SMZ, Minkove JA, Zebley JW, Mulholland JH. Severe but reversible neurotoxicity from acyclovir (letter). Ann Intern Med 1984; 100: 920.
12. Davenport A, Goel S, Mackenzie JC. Neurotoxicity of acyclovir in patients with end-stage renal failure treated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1992; 20: 647-9.
13. Swan SK, Bennett WM. Oral acyclovir and neurotoxicity (letter). Ann Intern Med 1989; 111: 188.
14. MacDiarmaid-Gordon AR, O'Connor M, Beaman M, Ackrill P. Neurotoxicity associated with oral acyclovir in patients undergoing dialysis. Nephron 1992; 62: 280-3.
15. Beales P, Almond MK, Kwan JTC. Acyclovir neurotoxicity following oral therapy: prevention and treatment in patients on haemodialysis (letter). Nephron 1994; 66: 362- 3.
16. Laskin OL, Longstreth JA, Whelton A, et al. Effect of renal failure on the pharmacokinetics of acyclovir. Am J Med 1982; 73: 197-203.
17. Shah GM, Winer RL, Krasny HC. Acyclovir pharmacokinetics in a patient on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1986; 7: 507-10.
18. Seth SK, Visconti JA, Herbert LA, Krasny HC. Acyclovir pharmacokinetics in a patient on continuous ambulatory peritoneal dialysis. Clin Pharm 1985; 4: 320-2.
19. Almond M K, Fan S, Dhillon S, et al. Avoiding neurotoxicity in patients with chronic renal failure undergoing haemodialysis. Nephron 1995; 69; 428-32